{"id":133875,"date":"2026-10-23T16:02:57","date_gmt":"2026-10-23T07:02:57","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/7459-20261023-02_wp_earnings_guidance\/"},"modified":"2026-10-23T16:02:57","modified_gmt":"2026-10-23T07:02:57","slug":"7459-20261023-02_wp_earnings_guidance","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/","title":{"rendered":"Notice of Revision to Full-Year Consolidated Earnings Forecast"},"content":{"rendered":"<p>Revised the full-year consolidated earnings forecast for the fiscal year ending March 2027. Net sales of 3,944,000 hundred million yen remain unchanged from the previous forecast, operating income and ordinary income remain unchanged, net income attributable to owners of parent increased from 43,000 hundred million yen to 53,000 hundred million yen, and basic earnings per share revised upward from 210.06 yen to 258.92 yen. The primary reason is the expected recognition of special gains due to the sale of investment securities.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7459","jir_company_name":"MediPal Holdings Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7459-20261023-02.pdf","jir_short_summary":"Revised the full-year consolidated earnings forecast for the fiscal year ending March 2027. Net sales of 3,944,000 hundred million yen remain unchanged from the previous forecast, operating income and ordinary income remain unchanged, net income attributable to owners of parent increased from 43,000 hundred million yen to 53,000 hundred million yen, and basic earnings per share revised upward from 210.06 yen to 258.92 yen. The primary reason is the expected recognition of special gains due to the sale of investment securities.","jir_summary":"### Summary of Forecast Revision\nIn today's announced revision to the full-year consolidated earnings forecast, net sales, operating income and ordinary income remain unchanged from the previous forecast, while net income attributable to owners of parent and basic earnings per share were revised upward. The primary reason is the expected increase in net income due to the recognition of gains on sale of investment securities (special gains) and the impact of reducing strategic investment holdings.\n\n### Outlook and Cautionary Notes\nThe consolidated earnings forecast is based on information available as of the announcement date, and actual results may differ depending on future developments. Investors should note that one-time factors such as the recognition of special gains may affect results.","jir_financial_highlights":"Net Sales: 3,944,000 hundred million yen (Same as previously announced forecast (A))\nOperating Income: 53,500 million yen (Same as previously announced forecast (A))\nOrdinary Income: 67,500 million yen (Same as previously announced forecast (A))\nNet Income Attributable to Owners of Parent: 53,000 million yen (+10,000 million yen compared with previous forecast (B))\nBasic Earnings Per Share: 258.92 yen (+48.86 yen compared with previous forecast (B))","jir_category":"","jir_hashtags":"#MediPalHoldings, #FullYearForecastRevision","jir_key_figures":"Net Sales: 3,944,000 hundred million yen\nNet Income Attributable to Owners of Parent: 53,000 million yen\nBasic Earnings Per Share: 258.92 yen","jir_meta_title":"MediPal Holdings Corporation: Revision to Full-Year Forecast\uff5cProfit Upward Revision Driven by Special Gains","jir_meta_description":"MediPal Holdings Corporation has revised its consolidated full-year earnings forecast for the fiscal year ending March 2027. Net sales unchanged while net income attributable to owners of parent has been increased. EPS also revised upward. The primary factor is the recognition of special gains.","jir_og_title":"MediPal Holdings Corporation Revises Full-Year Forecast Upward; Net Income Increased","jir_og_description":"MediPal Holdings Corporation has revised its full-year forecast for the fiscal year ending March 2027. Recognition of special gains is expected to push net income higher and raise per-share earnings. See details.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7774,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-133875","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice of Revision to Full-Year Consolidated Earnings Forecast - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/\",\"name\":\"Notice of Revision to Full-Year Consolidated Earnings Forecast - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-10-23T07:02:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice of Revision to Full-Year Consolidated Earnings Forecast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice of Revision to Full-Year Consolidated Earnings Forecast - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/","url":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/","name":"Notice of Revision to Full-Year Consolidated Earnings Forecast - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-10-23T07:02:57+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-7459\/ir\/7459-20261023-02_wp_earnings_guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice of Revision to Full-Year Consolidated Earnings Forecast"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"7774","title":"MEDIPAL HOLDINGS CORP","ticker":"7459"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/133875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=133875"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/133875\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=133875"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=133875"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=133875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}